Skip to main content
SpringerLink
Log in

Innovations in drug treatment of atrial fibrillation

  • Published:
Clinical Research in Cardiology Supplements Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Ehrlich JR, Biliczki P, Hohnloser SH, Nattel S (2008) Atrial-selective approaches for the treatment of atrial fibrillation. J Am Coll Cardiol 51:787–792

    Article  PubMed  CAS  Google Scholar 

  2. Kumar K, Zimetbaum PJ (2009) New and emerging antiarrhythmic drugs for atrial fibrillation: what may become available to the clinician in the near future. Curr Treat Options Cardiovasc Med 11:373–380

    Article  PubMed  Google Scholar 

  3. Connolly SJ, Crijns HJ, Torp-Pedersen C et al (2009) Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation 120:1174–1180

    Article  PubMed  CAS  Google Scholar 

  4. Singh BN, Connolly SJ, Crijns HJ et al (2007) Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 357:987–999

    Article  PubMed  CAS  Google Scholar 

  5. Hohnloser SH, Crijns HJ, van Eickels M et al (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360:668–678

    Article  PubMed  CAS  Google Scholar 

  6. Touboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH (2003) Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 24:1481–1487

    Article  PubMed  CAS  Google Scholar 

  7. Davy JM, Herold M, Hoglund C et al (2008) Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 156:527 (e521–529)

    Article  PubMed  Google Scholar 

  8. Naccarelli GV, Wolbrette DL, Samii S et al (2008) Vernakalant: pharmacology electrophysiology, safety and efficacy. Drugs Today (Barc) 44:325–329

    Article  CAS  Google Scholar 

  9. Roy D, Pratt CM, Torp-Pedersen C et al (2008) Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation 117:1518–1525

    Article  PubMed  CAS  Google Scholar 

  10. Kowey PR, Dorian P, Mitchell LB et al (2009) Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol 2:652–659

    Article  PubMed  Google Scholar 

  11. Jongsma H (1998) Sudden cardiac death: a matter of faulty ion channels? Curr Biol 13; 8(16):568–571

    Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Dept. of Internal Medicine, Heart, Vascular and Arrhythmia Center Rhineland-Bonn, St. Marienhospital Bonn Academic Hospital, University of Bonn, Robert-Koch-Str. 1, 53115, Bonn, Germany

    Nadina Stadler PhD &  Thorsten Lewalter MD (Head)

Authors
  1. Nadina Stadler PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thorsten Lewalter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thorsten Lewalter MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stadler, N., Lewalter, T. Innovations in drug treatment of atrial fibrillation. Clin Res Cardiol Suppl 5 (Suppl 1), 47–50 (2010). https://doi.org/10.1007/s11789-010-0001-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11789-010-0001-3

Keywords

Search

Navigation